Davide Gentile - Search Results

Year	Number of Results
2018	5
2019	7
2020	6
2021	0

1

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.

Gentile D, Patamia V, Scala A, Sciortino MT, Piperno A, Rescifina A. Gentile D, et al. Mar Drugs. 2020 Apr 23;18(4):225. doi: 10.3390/md18040225. Mar Drugs. 2020. PMID: 32340389 Free PMC article.

2

New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine.

Gentile D, Fuochi V, Rescifina A, Furneri PM. Gentile D, et al. Int J Mol Sci. 2020 Aug 14;21(16):5856. doi: 10.3390/ijms21165856. Int J Mol Sci. 2020. PMID: 32824072 Free PMC article.

3

Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.

Salerno L, Floresta G, Ciaffaglione V, Gentile D, Margani F, Turnaturi R, Rescifina A, Pittalà V. Salerno L, et al. Among authors: gentile d. Eur J Med Chem. 2019 Apr 1;167:439-453. doi: 10.1016/j.ejmech.2019.02.027. Epub 2019 Feb 12. Eur J Med Chem. 2019. PMID: 30784878 Review.

4

Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water.

Gentile D, Floresta G, Patamia V, Nicosia A, Mineo PG, Rescifina A. Gentile D, et al. Org Biomol Chem. 2020 Feb 14;18(6):1194-1203. doi: 10.1039/c9ob02352f. Epub 2020 Jan 29. Org Biomol Chem. 2020. PMID: 31995083

5

Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands.

Floresta G, Dichiara M, Gentile D, Prezzavento O, Marrazzo A, Rescifina A, Amata E. Floresta G, et al. Among authors: gentile d. Int J Mol Sci. 2019 Jan 23;20(3):488. doi: 10.3390/ijms20030488. Int J Mol Sci. 2019. PMID: 30678129 Free PMC article.

6

Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach^†.

Floresta G, Patamia V, Gentile D, Molteni F, Santamato A, Rescifina A, Vecchio M. Floresta G, et al. Among authors: gentile d. ChemMedChem. 2020 Jan 17;15(2):256-262. doi: 10.1002/cmdc.201900594. Epub 2019 Dec 9. ChemMedChem. 2020. PMID: 31774239

7

Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.

Floresta G, Gentile D, Perrini G, Patamia V, Rescifina A. Floresta G, et al. Among authors: gentile d. Mar Drugs. 2019 Oct 31;17(11):624. doi: 10.3390/md17110624. Mar Drugs. 2019. PMID: 31683588 Free PMC article.

8

Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains.

Di Lodovico S, Napoli E, Di Campli E, Di Fermo P, Gentile D, Ruberto G, Nostro A, Marini E, Cellini L, Di Giulio M. Di Lodovico S, et al. Among authors: gentile d. Sci Rep. 2019 Mar 15;9(1):4646. doi: 10.1038/s41598-019-40991-y. Sci Rep. 2019. PMID: 30874618 Free PMC article.

9

Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products.

Floresta G, Amata E, Gentile D, Romeo G, Marrazzo A, Pittalà V, Salerno L, Rescifina A. Floresta G, et al. Among authors: gentile d. Mar Drugs. 2019 Feb 12;17(2):113. doi: 10.3390/md17020113. Mar Drugs. 2019. PMID: 30759842 Free PMC article.

10

Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation.

Amata E, Dichiara M, Gentile D, Marrazzo A, Turnaturi R, Arena E, La Mantia A, Tomasello BR, Acquaviva R, Di Giacomo C, Rescifina A, Prezzavento O. Amata E, et al. Among authors: gentile d. ACS Med Chem Lett. 2020 Apr 9;11(5):889-894. doi: 10.1021/acsmedchemlett.9b00661. eCollection 2020 May 14. ACS Med Chem Lett. 2020. PMID: 32435401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results